KH
Kazunori Hirokawa
About Kazunori Hirokawa
Data last updated:
Kazunori Hirokawa was a Director at Daiichi Sankyo India Pharma Private Limited (2011–2012) and Director at Ranbaxy Laboratories Ltd (from 2012). The companies operate in Media and Publishing.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Daiichi Sankyo India Pharma Private Limited U24233HR2007PTC044362 | Director | 06 Jun 2011 | 2007 | ₹185 Cr (FY 2015) | Dissolved (Liquidated) |
 Ranbaxy Laboratories Ltd L24231PB1961PLC003747 | Director | 09 May 2012 | 1961 | ₹1.3 Lakh (FY 2014) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kazunori Hirokawa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kazunori Hirokawa
Kazunori Hirokawa was first appointed on 06 Jun 2011 as Director at Daiichi Sankyo India Pharma Private Limited. The most recent appointment on record is 09 May 2012 at Ranbaxy Laboratories Ltd.
Kazunori Hirokawa held 2 earlier board appointments: Daiichi Sankyo India Pharma Private Limited (Director, 06 Jun 2011 to 01 Apr 2012); Ranbaxy Laboratories Ltd (Director, from 09 May 2012).